Do multiple Borrelia-specific IgG antibodies indicate prior immune exposure rather than active infection?

Borrelia-specific IgG reactivity is best understood as evidence of immunologic exposure, not a stand-alone marker of viable, symptomatic infection. This distinction is particularly important when interpreting positive results in an older adult, in whom remote exposure and unrelated causes of nonspecific symptoms may coexist.

Clinical interpretation

• Multiple IgG reactions are more persuasive than an isolated antigen band when they meet validated multi-antigen/two-tier testing criteria. They are consistent with Borrelia burgdorferi infection or exposure in either the recent or remote past.
• However, a positive IgG result cannot date the exposure, attribute current symptoms to Lyme disease, establish treatment failure, or document cure. In long-term follow-up, IgG remained detectable in 62% of patients with prior Lyme arthritis 10–20 years later.
• Current clinical relevance requires a compatible syndrome, exposure history, timing, and objective findings; serology should not be used alone to explain prolonged nonspecific symptoms.

Mechanistic and diagnostic considerations

• Antibody persistence reflects durable immune memory rather than proof that viable organisms remain. Both IgM and IgG may persist for months to years, and IgG potentially for decades, after eradication or successful treatment.
• The converse also applies early in illness: during the first 4–6 weeks, before seroconversion, active infection can yield negative antibody testing; early antibiotics can blunt antibody development.
• PCR is not a definitive arbiter of activity. Negative PCR, especially in blood or CSF where organism burden may be sparse, does not exclude infection. Positive PCR detects DNA, which can persist after organisms are nonviable, and therefore also requires syndrome- and specimen-specific interpretation.

Bottom line

• Multiple Borrelia-specific IgG antibodies support prior immune exposure, but neither serology nor PCR alone establishes active infection; diagnosis of active Lyme disease depends on clinical correlation and appropriate testing in the relevant syndrome.